Skip to main content

Table 1 Genotype of SMA patients.

From: Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy

Biopsy code

SMA

type

Sex

Age at biopsy

(years)

SMN1

Deletion

SMN2

copy number

NAIP

deletion

SMA I samples

A

1A

M

0,2

7,8 ex.

2

NO

B

1B

F

0,3

7 ex.

2

NO

C

1B

M

0,5

7,8 ex.

2

NO

D

1B

F

0,9

7,8 ex.

2

NO

SMA I control

Cont. 1

NO

M

0,6

NO

-

NO

SMA III samples

E

3A

M

7

7 ex.

3

NO

F

3A

F

7

7,8 ex.

2

NO

G

3A

F

8

7,8 ex.

3

NO

H

3A

F

7

7,8 ex.

4

NO

I

3A

F

11

7,8 ex.

4

NO

SMA III control

Cont. 2

NO

M

8

NO

-

NO

  1. High-molecular weight genomic DNA was obtained from all patients with SMA type I and III enrolled for this study. This was used to control for the presence of SMN1 and NAIP gene deletions and SMN2 copy number. Genomic DNA from age-matched unaffected donors was used to perform parallel control analyses.